Dr. Amit Vatkar
MBBS, DCH, DNB Pediatrics
Fellow in Pediatric Neurology, Mumbai
Trained in Neurophysiology & Epilepsy, USA
Contact No. : +91-8767844488
Email: vatkaramit@yahoo.com
RECENT UPDATES IN
CHILDHOOD
TUBERCULOSIS
Tuberculosis – the facts
• Most cases occurred in
– Asia (59%) and
– Africa (26%)
WHO report 2011
Tuberculosis estimates in India
RESISTANCE PATTERN OF TB INDIA
Pathogens found in lungs from autopsy
studies of African children
TB disease and infection -
definitions
TB disease
• Detection of M. tuberculosis and/or clinical
symptoms compatible with tuberculosis
Latent infection with M. tuberculosis (LTBI)
• Presence of an immune response in a skin test
or an IFN-γ release assay (IGRA)
• Absence of clinical symptoms
Diagnosis of active tuberculosis
• Patient history
• Chest X-ray
• Culture
• Acid-fast bacilli staining
• Nucleic acid amplification testing
PRESUMPTIVE DRUG RESISTANT TB
Investigations in pipeline
NEW GROUPING OF DRUGS
REGIMEN OF DRUGS
TREATMENT REGIMENS IN RESISTANT TUBERCULOSIS
CONTACT
TUBERCULIN SKIN TEST
• Two preparations of PPD are available - PPD-S
and PPD RT23.
• Two TU PPD RT23 withTween 80 is equivalent to
5 TU of PPD-S.
• Current recommendation is to use 2 TU RT23.
• If it is not available 5 TU is acceptable, but there
a risk of false positivity.
• Cut off for positive result is an induration of 10
mm. In HIV positive patients 5 mm is the cut off.
New TB diagnostic tools
Between 2007 and 2010 the WHO has recommended
several new diagnostic tests to improve TB diagnosis:
– Fluorescent microscopy using LED technology—2009
– Liquid culture: MGIT (mycobacterium growth
indicator
tubes) and MODS (microscopic observation drug
susceptibility assay)—2007/2009
– Nucleic Acid Amplification Test (NAAT):
Xpert MTB/RIF—2010
Gene- Xpert Procedure
Multiple Cartrige System
Performance of Xpert MTB/RIF vs. other diagnostic modalities
Boehme et., Lancet 2011
Liquid culture: MGIT (mycobacterium growth
indicator tubes) and MODS (microscopic
observation
drug susceptibility assay).Advantages
+ Both are a lot faster than solid
media
(2 wks vs. 3-6 wks).
+ MGIT had 81.5% sensitivity and
99.6% specificity in detecting MTB.
+ MGIT results had high concordance
with solid media: 97% for rifampin
and 96% for isoniazid resistance.
+ MODS is close to 98% sensitive and
nearly 99% specific in detecting
rifampin resistance, and 98%
sensitive and 96% specific for
isoniazid resistance.
+ MODS is inexpensive.
Disadvantages
- Both MGIT and MODS require
trained technicians, sample
processing, and biosafety levels
appropriate only for reference
laboratory settings.
- MGIT is costly (@$30,000 per
machine and $5 for a tube).
- MGIT also requires another test 
to do rapid speciation to
distinguish between MTB and
non-TB mycobacteria.
- MODS may have standardization 
issues that can hamper its
accuracy.
Nucleic acid amplification test
(NAAT): Xpert MTB/RIF
Xpert MTB/RIF
Advantages Disadvantages
98% sensitivity
in smear-positive samples
expensive
machinery: currently about
$17,000 for the machine and
$17 per cartridge
specificity is 99%. requires electric
supply and annual calibration
Gives results within 2 hours Does not test resistance to
drugs other than rifampicin
Requires minimal sample
preparation
NEONATED OF MOTHER WITH TUBERCULOSIS
• INH prophylaxis (10 mg/kg) for 6 months to all the babies-
diagnosed to have active TB during pregnancy, after delivery
or exposed to any case of active disease after delivery.
• Rule out congenital TB
• practical purpose RNTCP recommends BCG vaccination at
birth even if INH chemoprophylaxis is planned.
• Isolation of baby is indicated only if mother is having a
smear positive MDR TB.
• Isolation may be considered when mother is sick, non
adherent to therapy, received ATT for less than 2 weeks or
suspected to have MDR TB.
• Barrier nursing, using face mask and appropriate cough
hygiene are advised for all the mothers.
Recommendation
Xpert MTB/RIF should be used rather than
conventional microscopy and culture as the initial
diagnostic test in children suspected of having
• children suspected of having TB
• MDR TB or HIV-associated TB
• extrapulmonary TB
• TB meningitis
DIAGNOSIS OF ETB
STEROIDS IN ETB
DURATION OF ATT IN ETB
Dr. Amit Vatkar
Pediatric Neurologist, Navi Mumbai
MBBS, DNB
Email: vatkaramit@yahoo.com
Contact No.: +91-8767844488
Visit us at: http://pediatricneurology.in/
THANK YOU !

Recent advances in tuberculosis

  • 1.
    Dr. Amit Vatkar MBBS,DCH, DNB Pediatrics Fellow in Pediatric Neurology, Mumbai Trained in Neurophysiology & Epilepsy, USA Contact No. : +91-8767844488 Email: vatkaramit@yahoo.com RECENT UPDATES IN CHILDHOOD TUBERCULOSIS
  • 2.
    Tuberculosis – thefacts • Most cases occurred in – Asia (59%) and – Africa (26%) WHO report 2011
  • 3.
  • 4.
  • 5.
    Pathogens found inlungs from autopsy studies of African children
  • 6.
    TB disease andinfection - definitions TB disease • Detection of M. tuberculosis and/or clinical symptoms compatible with tuberculosis Latent infection with M. tuberculosis (LTBI) • Presence of an immune response in a skin test or an IFN-γ release assay (IGRA) • Absence of clinical symptoms
  • 7.
    Diagnosis of activetuberculosis • Patient history • Chest X-ray • Culture • Acid-fast bacilli staining • Nucleic acid amplification testing
  • 8.
  • 9.
  • 13.
  • 14.
  • 15.
    TREATMENT REGIMENS INRESISTANT TUBERCULOSIS
  • 18.
  • 19.
    TUBERCULIN SKIN TEST •Two preparations of PPD are available - PPD-S and PPD RT23. • Two TU PPD RT23 withTween 80 is equivalent to 5 TU of PPD-S. • Current recommendation is to use 2 TU RT23. • If it is not available 5 TU is acceptable, but there a risk of false positivity. • Cut off for positive result is an induration of 10 mm. In HIV positive patients 5 mm is the cut off.
  • 20.
    New TB diagnostictools Between 2007 and 2010 the WHO has recommended several new diagnostic tests to improve TB diagnosis: – Fluorescent microscopy using LED technology—2009 – Liquid culture: MGIT (mycobacterium growth indicator tubes) and MODS (microscopic observation drug susceptibility assay)—2007/2009 – Nucleic Acid Amplification Test (NAAT): Xpert MTB/RIF—2010
  • 21.
  • 22.
  • 23.
    Performance of XpertMTB/RIF vs. other diagnostic modalities Boehme et., Lancet 2011
  • 24.
    Liquid culture: MGIT(mycobacterium growth indicator tubes) and MODS (microscopic observation drug susceptibility assay).Advantages + Both are a lot faster than solid media (2 wks vs. 3-6 wks). + MGIT had 81.5% sensitivity and 99.6% specificity in detecting MTB. + MGIT results had high concordance with solid media: 97% for rifampin and 96% for isoniazid resistance. + MODS is close to 98% sensitive and nearly 99% specific in detecting rifampin resistance, and 98% sensitive and 96% specific for isoniazid resistance. + MODS is inexpensive. Disadvantages - Both MGIT and MODS require trained technicians, sample processing, and biosafety levels appropriate only for reference laboratory settings. - MGIT is costly (@$30,000 per machine and $5 for a tube). - MGIT also requires another test  to do rapid speciation to distinguish between MTB and non-TB mycobacteria. - MODS may have standardization  issues that can hamper its accuracy.
  • 25.
    Nucleic acid amplificationtest (NAAT): Xpert MTB/RIF Xpert MTB/RIF Advantages Disadvantages 98% sensitivity in smear-positive samples expensive machinery: currently about $17,000 for the machine and $17 per cartridge specificity is 99%. requires electric supply and annual calibration Gives results within 2 hours Does not test resistance to drugs other than rifampicin Requires minimal sample preparation
  • 27.
    NEONATED OF MOTHERWITH TUBERCULOSIS • INH prophylaxis (10 mg/kg) for 6 months to all the babies- diagnosed to have active TB during pregnancy, after delivery or exposed to any case of active disease after delivery. • Rule out congenital TB • practical purpose RNTCP recommends BCG vaccination at birth even if INH chemoprophylaxis is planned. • Isolation of baby is indicated only if mother is having a smear positive MDR TB. • Isolation may be considered when mother is sick, non adherent to therapy, received ATT for less than 2 weeks or suspected to have MDR TB. • Barrier nursing, using face mask and appropriate cough hygiene are advised for all the mothers.
  • 28.
    Recommendation Xpert MTB/RIF shouldbe used rather than conventional microscopy and culture as the initial diagnostic test in children suspected of having • children suspected of having TB • MDR TB or HIV-associated TB • extrapulmonary TB • TB meningitis
  • 29.
  • 30.
  • 31.
  • 32.
    Dr. Amit Vatkar PediatricNeurologist, Navi Mumbai MBBS, DNB Email: vatkaramit@yahoo.com Contact No.: +91-8767844488 Visit us at: http://pediatricneurology.in/ THANK YOU !